Rapiflux

Name: Rapiflux

Rapiflux Overview

Fluoxetine is a prescription medicine used to treat depression, obsessive compulsive disorder (OCD), bulimia, and panic disorder. Fluoxetine belongs to a group of drugs called selective serotonin reuptake inhibitor (SSRI). It works by changing the levels of certain chemicals in the brain that affect your mood.

Fluoxetine is available in capsule, tablet, and a liquid forms. It is usually taken once or twice daily, with or without food. Common side effects of fluoxetine include unusual dreams, sexual problems, and loss of appetite. Fluoxetine hydrochloride can also cause dizziness or drowsiness. Do not drive or operate heavy machinery until you know how fluoxetine hydrochloride affects you.

Rapiflux Food Interactions

Medicines can interact with certain foods. In some cases, this may be harmful and your doctor may advise you to avoid certain foods. In the case of fluoxetine there are no specific foods that you must exclude from your diet when receiving fluoxetine.

Rapiflux FDA Warning

WARNING–SUICIDALITY AND ANTIDEPRESSANT DRUGS

Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of Major Depressive Disorder (MDD) and other psychiatric disorders. Anyone considering the use of fluoxetine or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. Fluoxetine is approved for use in pediatric patients with MDD and Obsessive Compulsive Disorder (OCD). 

When using fluoxetine and olanzapine in combination, also refer to Boxed Warning section of the package insert for olanzapine and fluoxetine hydrochloride capsules.

(web3)